Literature DB >> 8240743

Is chronic graft versus host disease an autoimmune disease?

R Parkman1.   

Abstract

Chronic graft versus host disease continues to be a major problem following bone marrow transplantation even though the incidence and severity of acute graft versus host disease has been reduced. Recent investigations have suggested that the pathogenesis of chronic graft versus host disease is more similar clinically to an autoimmune disease than to acute graft versus host disease.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8240743     DOI： 10.1016/0952-7915(93)90140-n

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  11 in total

1.  Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes.

Authors:  W J Murphy
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.

Authors:  James S Young; Tao Wu; Yuhong Chen; Dongchang Zhao; Hongjun Liu; Tangsheng Yi; Heather Johnston; Jeremy Racine; Xiaofan Li; Audrey Wang; Ivan Todorov; Defu Zeng
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

3.  STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.

Authors:  Vedran Radojcic; Maria A Pletneva; Hung-Rong Yen; Sanja Ivcevic; Angela Panoskaltsis-Mortari; Anita C Gilliam; Charles G Drake; Bruce R Blazar; Leo Luznik
Journal:  J Immunol       Date:  2009-12-07       Impact factor: 5.422

4.  Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.

Authors:  Peilong Lai; Jianyu Weng; Zesheng Lu; Rong Guo; Chenwei Luo; Suijing Wu; Wei Ling; Suxia Geng; Xin Du
Journal:  DNA Cell Biol       Date:  2011-06-17       Impact factor: 3.311

5.  Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.

Authors:  Dongchang Zhao; James S Young; Yu-Hong Chen; Elizabeth Shen; Tangsheng Yi; Ivan Todorov; Peiguo G Chu; Stephen J Forman; Defu Zeng
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

Review 6.  High-dose cyclophosphamide for graft-versus-host disease prevention.

Authors:  Leo Luznik; Richard J Jones; Ephraim J Fuchs
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

7.  PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.

Authors:  Kathryn W Juchem; Faruk Sacirbegovic; Cuiling Zhang; Arlene H Sharpe; Kerry Russell; Jennifer M McNiff; Anthony J Demetris; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

8.  Emergent autoimmunity in graft-versus-host disease.

Authors:  Elizabeth Tivol; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

9.  Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.

Authors:  Tao Wu; James S Young; Heather Johnston; Xiong Ni; Ruishu Deng; Jeremy Racine; Miao Wang; Audrey Wang; Ivan Todorov; Jianmin Wang; Defu Zeng
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422

Review 10.  Reconstitution of self-tolerance after hematopoietic stem cell transplantation.

Authors:  Allan D Hess
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.